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Background: An imbalance between pro-oxidants and antioxidant systems has been suggested to be implicated in
the physiopathology of acute myocardial infarction (AMI). We aimed to evaluate the antioxidant capacity in
Tunisian patients and to assess the possible relationship between erythrocyte catalase enzyme activity and
hyperhomocysteinaemia.
Methods: 108 patients with AMI and 81 healthy subjects were enrolled in this study. Catalase erythrocyte enzyme
activity was determined spectrophotometrically whereas “total antioxidant status” (TAS) concentration was
measured by a commercially available method. Serum total homocysteine (tHcy) level was determined by a
fluorescence polarization immunoassay (FPIA). Lipid peroxidation was measured with a fluorimetric method as
“thiobarbituric acid reactive substances” (TBARS).
Results: Compared with healthy subjects, patients with AMI had significantly lower catalase activity (P<0.001), TAS
concentrations (P<0.001), and significantly higher serum tHcy (P<0.001) and TBARS levels (P<0.001). Erythrocyte
catalase enzyme activity was negatively correlated with serum tHcy and TBARS while serum tHcy and TBARS were
in positive correlation. Furthermore, the unbalance between pro-oxidants and antioxidants seems to be more
aggravated in patients with Q wave AMI compared to patients with non-Q wave AMI.
Conclusion: Our results suggest the involvement of hyperhomocysteinaemia in the drop of erythrocyte catalase
activity related to myocardial ischemia reperfusion. Hyperhomocysteinaemia may increase the myocardial wall
dysfunction under ischemia reperfusion by excessive production of reactive oxygen species which is made evident
by increased lipid peroxidation.
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Myocardial infarction is a major cause of morbidity and
mortality worldwide. Recently, an increase in the inci-
dence of coronary heart disease (CHD) has been
recorded in Tunisian cardiovascular disease register.
Among diabetes, hypertension, abdominal obesity and
smoking, a family lipoprotein disorder such as a high
level of serum apolipoprotein B (Apo B) or/and a lower
level of serum apolipoprotein A-1 accounted for almost
all the population attributable risk of AMI [1,2]. Simi-
larly, hyperhomocysteinaemia related to nutritional or
genetic factors, such as methylenetetrahydrofolate re-
ductase, endothelial nitric oxide synthase genes or with
low paraoxonase activity led to increased risk of CHD
severity. It can induce sustained injury of arterial endo-
thelial cells and proliferation of arterial smooth muscle
cells [3].
Atherosclerotic plaques are the major cause of Myocar-
dial infarction. Other unusual causes of MI can be related
to myocardial necrosis, or Thiamine deficiency causing al-
terations in heart metabolism [4,5]. Coronary artery occlu-
sion can result in a reduction in myocardial blood flow
[6]. In fact, myocardial ischemia occurs when myocardial
oxygen demand exceeds the oxygen supply. Reperfusion
of the ischemic myocardium can restore, afterwards, the
blood flow but sudden massive increase in oxygen supply
can lead to additional myocardial cell dysfunction and cell
necrosis. Excessive production of Reactive Oxygen Species
(ROS) has been most importantly proposed to mediate
ischemia reperfusion injury. These species are toxic and
may cause potential biological damage to all cellular com-
ponents [7]. This occurs when there is an overproduction
of ROS on one side and a deficit or inadequate availability
of antioxidant systems on the other [6]. ROS generation
may induce irreversible myocardial cell necrosis or apop-
tosis through triggering DNA fragmentation and caspase
activation and causing myocardial injury [8,9]. Exposure
to ROS from a variety of sources led to develop a series of
defense mechanisms to neutralize these species and so
protect cells against their toxic effects. This is achieved
mainly by enzymatic antioxidants such as catalase, or by
non-enzymatic antioxidants such as vitamins. Catalase
is believed to play a major role in the first line of enzy-
matic antioxidant defense. It is a tetrameric enzyme,
consisting of four identical subunits that contain a sin-
gle ferriprotoporphoryn group per subunit. Catalase re-
acts efficiently in peroxisomes with hydrogen peroxide
(H202) to form water and molecular oxygen [10,11].
Hyperhomocysteinaemia and other cardiovascular risk
factors have been suggested to be implicated in the imbal-
ance aggravation between pro-oxidants and antioxidants
linked to its pro-oxidant properties or in the impairment
of antioxidant systems. The aim of our study is to evaluate
the total antioxidant capacity and erythrocyte catalaseactivity in patients hospitalized for AMI. We aimed to
access the possible relationships between erythrocyte cata-
lase activity, hyperhomocysteinaemia and the severity of
myocardial dysfunction under ischemia reperfusion.Materials and methods
Study population
The study consisted of 108 patients with a mean age of
63 ± 12 years admitted to the department of cardiology in
Farhad Hached hospital in Tunisia. The diagnostic of AMI
was established according to universal clinical criteria:
chest pain which lasted for up 3 hours, ECG changes and
serum troponin elevation. The control group consisted of
81 healthy volunteers with no history of coronary artery
disease, diabetes, hypertension or inflammatory disease.
Their mean of age was 59 ± 9 years.
The electrocardiographic changes were recorded and
assessed by 2 cardiologists who were unaware that the
patients are included in our study.
Coronary risk factors have been referred in our study
population according to universal definitions. Dyslipi-
demia was defined when total cholesterol concentration
was ≥ 5,68 mmol/l, or triglyceride concentration ≥ 2,28
mmol/l. Hyperhomocysteinaemia was defined by a
raised blood total homocysteine, exceeding 15 μmol/l.
Informed written consent was obtained from each
patient and healthy subject according to the guidelines
of our ethics’ committee.Blood collection and biochemical methods
Venous blood was collected after overnight fasting and
within 24 hours after admission for chest pain. Serum
was separated by centrifugation at 1500 g for 10 min, and
then stored at −80°C until the day of analysis. Serum was
used for the estimation of lipid peroxidation, total homo-
cysteine (tHcy), apolipoproteins (Apo A-1 and Apo B)
levels and total antioxidant status (TAS) concentration.
Total homocysteine in serum was measured by the
“Abbott homocysteine assay”, a fully automated fluores-
cence polarization immunoassay (FPIA) from Abbott diag-
nostics. Serum apolipoproteins (Apo A-1 and Apo B)
were measured by immunonephelometry (Dade Behring,
Marburg, Germany). Plasma TAS was measured with
commercial kit (Randox, Antrim, UK) according to the
method of Miller et al. [12]. It can evaluate the total
capacity of all antioxidants found in serum to neutralize
the oxidative action of free radicals. Lipid peroxidation
level was estimated by measurement of thiobarbituric
acid reactive substances (TBARS) in serum according to
the fluorimetric method of Yagi [13]. The pink chromo-
gen produced by the reaction of thiobarbituric acid with
lipid peroxidation products such as malondialdehyde
(MDA) was estimated using 1,1,3,3-tetraethoxypropane
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at 515 nm excitation and 553 nm emission.
Catalase activity was determined in washed red cells
prepared immediately after sampling from whole blood
anticoagulant with heparin. Then, cell lysates were stored
frozen. Catalase activity was measured according to the
spectrophotometric method of Goth [14]. This assay is
based on the ability of hydrogen peroxide to form a stable
stained complex with ammonium molybdate measured at
405 nm.
Statistical analysis
Database management and statistical analyses were carried
out using SPSS (Statistical Package for the Sociological
Sciences), version 17.0. Results are presented as means ±
SD, or percentages. Means were compared using Student
for independent samples. The relations between variables
were assessed with Pearson's correlation analysis. The
significance threshold was set at 5% (p<0.05).
Results
Clinical characteristics of patients with AMI and control
groups are illustrated in Table 1. No difference was found
between the 2 groups for the mean of age and sex. AmongTable 1 Clinical and biochemical features of patients with
acute myocardial infarction and controls
Patients (n= 108) Controls (n =81) P
Age (years) 63 ± 12 59 ± 9 NS
Men (%) 70 38
BMI (kg/m2) 27 ± 6 23 ± 3 NS
Diabetes mellitus (%) 61 0
Dyslipidemia (%) 45 0
Hypertension (%) 70 0
Smokers (%) 50 6
Alcohol (%) 25 0
Apo A1 (g/L) 1.26 ± 0.19 1.5 ± 0.17 <0.001
Apo B (g/L) 1.29 ± 0.36 0.92 ± 0.22 <0.001
TAS (mmol/L) 1.47 ± 0.38 1.71 ± 0.22 <0.001
Catalase (kU/g Hb) 283 ± 141 652 ± 104 <0.001
Homocysteine (μmol/L) 26.9 ± 15.47 14.75 ± 2.69 <0.001
TBARS (μmol/L) 1.31 ± 0.36 0.71 ± 0.12 <0.001
Troponine TnIc (μg/L) 5,04 ± 2,90 0
Q wave AMI 9,13 ± 2,18
Non Q wave AMI 4,09 ± 2,03
Treatment
Statins (%) 38 0
Beta-Blockers (%) 40 0
Ca-Blockers (%) 28 0
Diuretics (%) 37 0
Values are expressed as mean ± SD or percentage (%).
NS: not significant, BMI: body mass index, TAS: total antioxidant status.cardiovascular factors risk, diabetes, hypertension and
dyslipidemia are greatly mentioned in patients compared
with healthy subjects. Apolipoproteins disorder was ob-
served in patients. There was a significant increase in
serum Apo B level (<0.001) and a decreased serum Apo
A-1 level (<0.001) compared with serum apolipoprotein
levels in healthy subjects. In other hand, tHcy and TBARS,
as a marker of lipid peroxidation, tended to be increased in
patients whereas serum TAS concentrations and erythro-
cyte catalase activity were found lower than in controls.
We showed in Table 2 that erythrocyte catalase activity
tended to decrease with smoking and/or arterial hyperten-
sion as cardiovascular risk factors. Serum tHcy level was
significantly higher in hypertensive patients compared to
the normotensive patients.Erythrocyte catalase activity and serum tHcy level
according to the severity of the myocardial dysfunction
Thirty one patients had a distinct increase of Q wave in the
electrocardiogram established at the diagnostic. Patients
with Q wave AMI had a significantly lower erythrocyte
catalase activity, higher serum tHcy and TBARS levels
compared to patients with non Q wave AMI (Figure 1).Results of Pearson correlation
We studied the Pearson correlation between serum
tHcy, erythrocyte catalase activity and serum TBARS in
patients. We found that erythrocyte catalase activity is
negatively correlated with both serum tHcy and TBARS
(r=−0.38, p<0.001; r=−0.41, p<0.001) (Figures 2 and 3).Table 2 Erythrocyte catalase activity and serum total







Sex Men 294 ± 129 NS 25.8 ± 11.6 NS
Women 271 ± 152 28 ± 18.4
Diabetes Yes 290 ± 152 NS 26.3 ± 15.9 NS
No 268 ± 121 27.8 ± 14.9
Dyslipidemia Yes 282 ± 151 NS 26.5 ± 12.3 NS
No 279 ± 124 27.6 ± 19.6
Obesity Yes 298 ± 131 NS 24.7 ± 13.2 NS
No 268 ± 150 29.1 ± 17.2
Hypertension Yes 211 ± 90 < 0.001 30 ± 17 < 0.001
No 412 ± 95 20.3 ± 8.2
Smoking Yes 224 ± 105 < 0.001 28.4 ± 13.1 NS
No 377 ± 142 24.5 ± 18.7
Alcohol Yes 275 ± 148 NS 24.5 ± 18.7 NS
No 387 ± 135 28.6 ± 11







































Figure 1 Comparison between patients with Q wave AMI and
patients with non Q wave AMI according to serum total
homocysteine level (tHcy) (p<0.001) (a), to erythrocyte catalase
activity (p<0.001) (b) and to plasma TBARS level (p<0.05) (c).









Figure 2 Correlation between erythrocyte catalase activity and
serum total homocysteine in patients with AMI (r=-0.38,
p<0.001).
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with serum TBARS level (r=0.4; p<0.001) (Figure 4).Discussion
Myocardial infarction is a complex and multifactor disease
in which the cellular and molecular mechanisms contrib-
uting to myocardial injury need to be more defined. In our
data, investigation about oxidative stress parameters shows
an increased serum TBARS level, as a lipid peroxidation
marker, and a drop in the total antioxidant capacity in pa-
tients with AMI compared to healthy subjects. According
to our observation, Pasupathi et al. have considered that
the increased serum TBARS is a consequence to excessive












Figure 3 Correlation between erythrocyte catalase activity and










Figure 4 Correlation between serum total homocysteine (tHcy)
and TBARS levels in patients with AMI (r= 0.4, p<0.001).
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Other enzymatic and cellular sources are suggested to be
implicated in ROS generation. Some of these are related
to the uncoupling of mitochondrial electron transport in
consequence to the lack of oxygen supply under ischemia,
or to the impairment of NO synthase activity [7].
In our study, we observed a decrease in erythrocyte
catalase activity in patients compared to controls. Ac-
cumulation of hydrogen peroxide under ischemia re-
perfusion can also inhibit antioxidant enzymes (high
substrate inhibition) and alter its enzymatic conformation.
According to Senthil et al., the decreased activity of cata-
lase in patients with CHD could be due to the inactivation
of this enzyme by cross linking or to the impairment of
NO synthase. Nitrite oxide (NO) can bind reversibly to
ferric iron, inhibiting afterwards catalase activity [16,17].
Erythrocyte catalase activity tended to decrease in patients
with hypertension and smoking as the major cardiovascu-
lar risk factors. Cigarette smoke is an abundant source of
free radicals. It contains more than 1015 free radicals in-
cluding superoxide anion and NO. Chemical oxidants in
cigarette smoke can cause the oxidation of DNA encoding
for antioxidant proteins [18]. On the other hand, essential
Hypertension is subjected to increased oxidative stress. It
may damage the endothelium and impair endothelium-
dependent vascular relaxation. ROS can act on angioten-
sin converting enzyme to increase its catalytic activity
resulting in the increase in angiotensin II production,
which, in turn, is a major endogenous inducer of NADPH
oxidase. Oxidative stress, endothelial dysfunction and in-
flammation represent a key triad for the development and
progression of Coronary heart disease [19,20].
The imbalance between pro-oxidants and antioxidants
occurred under ischemia reperfusion can be aggravatedby hyperhomocysteinaemia. The moderate hyperhomo-
cysteinaemia revealed in patients can be reported to a
hereditary defect of any of the Hcy metabolic enzymes
(cystathionine β-synthase, methylene tetrahydrofolate
reductase) or to the depletion in folic acid and vitamin B6
or B12 [3]. Increased serum tHcy may cause endothelial
dysfunction by promoting free radicals. Homocysteine is
readily oxidized. Its auto-oxidation is catalyzed by transi-
tion metal ions, such as copper leading to homocystine,
homocysteine mixed disulfides and homocysteine thio-
lactone formation [21,22]. Homocysteine reduces the tran-
sition metal ion (Mn+) to generate a thioyl radical (Hcy°).
It is thought to react with homocysteine to generate a free
radical intermediate that reduces oxygen to superoxide
anion (O2°) and then to peroxide hydrogen generation
[3,23]. In our data, we have shown a negative correlation
between hyperhomocysteinaemia and erythrocyte catalase
activity in patients with AMI. Homocysteine has the abil-
ity to bind proteins and to form disulphide bridges with
cysteine residues within proteins. Milton N et al. suggest
that modification of cysteine residues by Homocysteine
may alter the enzymatic activity of catalase [24]. The ex-
cessive generation of ROS under ischemia reperfusion can
affect the red cell metabolism and the possible hemolysis
when more than 98% in blood catalase is located in
erythrocytes [25]. Now this is in line with other works
suggesting that Hcy can affect the antioxidant enzyme
expression. Nanako et al. reported that homocysteine
reduced the expression of superoxide dismutase (SOD)
mRNA in cultured rat smooth muscle cells [26]. Other
studies showed a positive correlation between plasma Hcy
and genomic damage related to DNA hypomethylation
which let us to suggest that Hcy can exert genotoxic effects
on DNA genes encoding for antioxidant proteins [27].
Reactive oxygen species generated by Hcy auto-oxidation
are involved through Fenton type reaction in lipid per-
oxidation. The serum tHcy and TBARS levels were
found higher in patients’ with electrocardiogram pre-
senting Q wave AMI compared to patients with non Q
wave MI. Myocardial Infarction with Q wave can be
used as a predictor of morbidity and mortality patterns
after Myocardial events. Desmarais PL and al showed
that individuals who had non-Q wave MI had better
survival rates for the first 3 years after myocardial re-
habilitation than did those who had Q wave MI [28].
Excessive lipid peroxidation can be directly involved in
the myocardial necrosis manifesting as a myocardial
wall dysfunction. Polyunsaturated fatty acids (PUFAs)
such as arachidonic, linolenic and linoleic acids present
the major targets for free radical attack. It has also been
suggested that lipid peroxidation might proceed not only
in plasma membranes but also in the nuclear membranes
close to chromosomes, due to the loss of membrane integ-
rity in cell membranes consisting of phospholipids. Lipid
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and Malondialdehyde (MDA) are toxic. HNE leads to a
decrease in protein thiols, disturbance of calcium homeo-
stasis, inhibition of DNA, RNA and protein synthesis, in-
hibition of respiration and glycolysis [29]. Furthermore,
HNE leads to mammalian cell death. It increases the ex-
pression of p53 family members as well as an increase of
expression of the Bax pro-apoptotic gene [30]. MDA is
able to interact with nucleic acid bases to form several dif-
ferent adducts and to exacerbate DNA oxidative damage,
including genes encoding for antioxidant proteins such as
catalase, glutathione peroxidase and SOD.Conclusion
Molecular mechanisms of myocardial necrosis under is-
chemia reperfusion need to be more defined. We have
shown that hyperhomocysteinaemia, as a cardiovascular
risk factor, may be involved in the drop of the enzymatic
antioxidant activity. Hyperhomocysteinaemia can be in-
volved in the excessive lipid peroxidation due to its pro-
oxidant proprieties, aggravating the magnitude of the
oxidative stress and the severity of the myocardial wall
dysfunction. Further insights into the molecular mecha-
nisms of the metabolic basis of hyperhomocysteinaemia
will prove invaluable in the treatment and the preven-
tion of cardiovascular diseases related to atherosclerosis.
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